Insider Transactions in Q2 2023 at Repligen Corp (RGEN)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 18
2023
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
686
+23.0%
|
-
|
|
May 18
2023
|
Rohin Mhatre |
BUY
Grant, award, or other acquisition
|
Direct |
686
+22.63%
|
-
|
|
May 18
2023
|
Manner Carrie Eglinton |
BUY
Grant, award, or other acquisition
|
Direct |
686
+24.04%
|
-
|
|
May 18
2023
|
Karen A Dawes |
BUY
Grant, award, or other acquisition
|
Direct |
798
+1.02%
|
-
|
|
May 18
2023
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
686
+8.3%
|
-
|
|
May 18
2023
|
Nicolas Barthelemy |
BUY
Grant, award, or other acquisition
|
Direct |
686
+19.87%
|
-
|
|
May 18
2023
|
Konstantin Konstantinov |
BUY
Grant, award, or other acquisition
|
Direct |
686
+35.99%
|
-
|
|
May 16
2023
|
Jon Snodgres Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
710
-1.86%
|
$109,340
$154.03 P/Share
|
|
May 16
2023
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-1.01%
|
$51,436
$154.03 P/Share
|
|
May 16
2023
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
710
-2.93%
|
$109,340
$154.03 P/Share
|
|
May 08
2023
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
500
+23.69%
|
$78,000
$156.18 P/Share
|
|
May 05
2023
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
500
+31.04%
|
$79,500
$159.19 P/Share
|
|
May 04
2023
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
500
+45.0%
|
$80,500
$161.15 P/Share
|
|
Apr 04
2023
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-1.87%
|
$54,442
$163.45 P/Share
|